Former Chief Judge, U.S. Court of Federal Claims
Judge Braden was appointed to the United States Court of Federal Claims on July 14, 2003, by President George W. Bush, after being confirmed by unanimous consent of the United States Senate. She was sworn into office by Senator Jeff Sessions. Her investiture was conducted on October 24, 2003 by Justice Sandra Day O’Connor and Justice Ruth Bader Ginsburg.
On January 28, 2015, Judge Braden was appointed by the American Law Institute as one of seven Judicial Advisors to the Restatement of the Law on Copyright. In 2013, Judge Braden was appointed to the Judges Special Committee of the American Intellectual Property Law Association and was named as Chair of the Intellectual Property Committee of the Advisory Council of the United States Court of Federal Claims. On March 23, 2012, Judge Braden received the Linn Inn Alliance Distinguished Service Medal at the New York Intellectual Property Lawyers Association Annual Dinner for her work with the American Inns of Court, dedicated to intellectual property law. On February 7, 2012, Judge Braden was appointed as Chair of the American Bar Association’s Section of Intellectual Property Law Task Force to consider how to more efficiently adjudicate "small" patent infringement cases. During 2010-2011, Judge Braden served as President of the Giles S. Rich American Inn of Court, which is affiliated with the United States Court of Appeals for the Federal Circuit. She was recognized at a ceremony in the United States Supreme Court in November 2011, when she received the American Inns of Court’s Platinum Distinction Award. Judge Braden also served as a Member of the Editorial Board of the American Intellectual Property Law Association.
In July 2009, Judge Braden was appointed as a Member of the Standing Committee on Ethics and Professional Responsibility-Judges Advisory Committee to the American Bar Association, on which she served until 2012. On February 14, 2007, Judge Braden was elected as a Member of the American Law Institute and was active in drafting Restatement of Law Third, Restitution and Unjust Enrichment. On October 22, 2004, she was inducted as a Senior Fellow of the ABA’s Administrative Law and Regulatory Section by Justice O’Connor at a ceremony held at the United States Supreme Court.
Prior to joining the bench, Judge Braden litigated complex federal and administrative law cases in private practice in trial and appellate courts. In particular, her work in the intellectual property area received favorable notice in the Wall Street Journal, New York Times, National Law Journal, and the Journal of the American Bar Association, and was featured in Interfaces on Trial: Intellectual Property and Interoperability In The Global Software Industry. In 1996, Judge Braden was honored by the Computer Law Association for winning multiple decisions in the Eastern District of New York, the Eastern District of Texas, the Second Circuit, and a certified question to the Supreme Court of Texas in Computer Assocs. Int’l, Inc. v. Altai Inc., a landmark case that changed the application of copyright law to computer software. In 1998, she also won a companion case brought in France before the Cour de Appel de Paris.
In private practice, Judge Braden represented a wide variety of client interests before almost every major department and federal agency, testified before the United States Congress on a variety of matters, and was a principal lobbyist for the Emergency Oil and Steel Loan Guarantee Act of 1999, that established a $1 billion federal loan guarantee program to assist bankrupt and troubled steel mills and small oil companies.
Judge Braden received a B.A. degree (1970) and J. D. degree (1973) from Case Western Reserve University in Cleveland, Ohio. She also attended post graduate courses at the Harvard Law School in the summer of 1978.
James T. Jensen Endowed Professor for Transactional Law & Director of the Program on Intellectual Property and Technology Law, University of Utah S.J. Quinney College of Law
Jorge L. Contreras is a Distinguished University Professor, the James T. Jensen Endowed Professor for Transactional Law and Director of the Program on Intellectual Property and Technology Law. He teaches and researches in the areas of intellectual property, property law, technical standardization, antitrust and science policy. In 2020 he received the University of Utah's Distinguished Research Award and is an elected member of the American Law Institute. He has testified before the U.S. Senate and House Subcommittees on Intellectual Property, and was awarded the Rossman Memorial Award by the Patent & Trademark Office Society in 2022.
Professor Contreras has written or edited fourteen books and published more than 150 scholarly articles and chapters. His book, The Genome Defense: Inside the Epic Legal Battle to Determine Who Owns Your DNA (NY: Hachette/Algonquin, 2021), has been praised by the NY Times, Wall St. Journal, Nature and numerous other outlets, and was named "Best Patent Law Book of the Year" by the international IPKat blog. His scholarly articles have appeared in leading scientific, legal and policy journals including Science, Nature, NYU Law Review, Georgetown Law Journal, Iowa Law Review and Antitrust Law Journal. He has been quoted by media outlets around the world including the New York Times, Wall Street Journal, Economist, Bloomberg, Washington Post, Korea Times and has been featured on C-SPAN, NPR, PRI and BBC shows and a range of podcasts and online news programs.
Professor Contreras currently serves Co-Chair of the Interdisciplinary Division of the ABA's Section of Science & Technology Law and a member of the Advisory Board of the American Antitrust Institute. He has previously served as Co-Chair of the National Conference of Lawyers and Scientists, a member of the National Academy of Sciences (NAS) Committee on Intellectual Property Management in Standard-Setting Processes, the National Institutes of Health (NIH) Council of Councils, the Advisory Council of NIH's National Center for the Advancement of Translational Sciences (NCATS), the National Advisory Council for Human Genome Research, and the Intellectual Property Rights Policy Committee of the American National Standards Institute (ANSI). In 2021 he served as Chair of the Art Law Section of the Association of American Law Schools (AALS) and currently serves as Chair of the AALS Remedies Section.
Professor Contreras has previously taught at American University Washington College of Law and Washington University in St. Louis. Prior to entering academia he was a partner at the international law firm Wilmer Cutler Pickering Hale and Dorr LLP, where he practiced transactional and intellectual property law in Boston, London and Washington DC. He is a cum laude graduate of Harvard Law School (JD) and Rice University (BA, BSEE) and clerked for Chief Justice Thomas R. Philips of the Texas Supreme Court.
Vice President of Domestic Policy, National Association of Manufacturers
Charles Crain is the Vice President of Domestic Policy at the National Association of Manufacturers. In this role, he leads the association’s policy development and advocacy work on economic policy issues critical to the success of manufacturing in the United States, including tax, corporate governance, technology, health care, regulatory reform, and immigration. Prior to taking on the VP role, Charles led the NAM’s corporate finance policy portfolio, focused primarily on engagement with the Securities and Exchange Commission. He previously worked on Capitol Hill for members of the Senate Finance and House Financial Services Committees and was the Director of Tax and Financial Services Policy at the Biotechnology Innovation Organization.
Senior Counsel for Law and Policy, Committee for Justice
Jeff is a registered patent attorney and an intellectual property and innovation policy professional with a unique combination of training and real-world experience. Jeff is also currently a PhD candidate at the University of Pittsburgh Graduate School of Public and International Affairs (GSPIA). His dissertation is entitled “An Inquiry into the Nature and Causes of American Innovation: An Austrian Economics Perspective.”
Jeff maintains an active intellectual property law practice in the life sciences space. While counseling clients and working on his dissertation and other scholarship, Jeff remains active in the policy analysis and advocacy space. He currently serves as the President of the Association for American Innovation and a member and former Chair of the Public Policy Legal Task Force (PPLTF) for the Association of University of Technology Managers (AUTM).
Jeff has a bachelor’s degree chemical and biomedical engineering with concentrations in molecular biology and fermentation technology and from Carnegie Mellon. He also has a master’s degree in industrial administration (business) from Carnegie Mellon where he concentrated on international management, marketing and finance. He earned his law degree from the Duquesne University School of Law with a focus on intellectual property law.
Senior Partner, ACG Advocacy
Chris Israel is a Senior Partner at ACG Advocacy and is also the co-lead of the firm’s technology and intellectual property group.
He joined ACG in 2010, after serving in the George W. Bush Administration as Deputy Chief of
Staff to the Secretary of Commerce and later becoming the first U.S. International Intellectual
Property Enforcement Coordinator.
At ACG Advocacy, Chris works with a diverse range of clients including some of the largest and
most innovative companies in the world to support their efforts to build a policy environment in the U.S. that promotes and protects their investments in intellectual property. He has also
developed a unique focus leading a coalition of top venture capitalists and innovative startups to pursue a policy agenda that has led to improvements in tax policy, investments in R&D, and
strengthening patent protection.
Chris maintains a leadership profile working on IP and innovation issues and has been a frequent public speaker and has testified before Congress multiple times both as an Administration official and since he left public service. He was previously named one of the 50 “Most Influential People on IP” by Managing Intellectual Property magazine.
His international experience in government, particularly in working with China, has enabled him to successfully engage clients on global trade and technology matters ranging from the
negotiations of trade agreements, tariff policy, and engaging international organizations. His
client relationships have included automakers, global manufacturing companies, shipping
companies, and Chinese e-commerce and social media platforms seeking to better understand the U.S. market.
Chris’ experience leading coalitions has also included serving as Executive Director of the
musicFIRST Coalition during the lead-up to the passage of the landmark Music Modernization
Act. During this time he was named to Medium’s inaugural “Power 10” list of music policy
leaders.
Within ACG Advocacy, he provides guidance on the firm’s day-to-day interaction with all its
clients and helps lead ACG’s extensive policy research team. He has also launched the firm’s
podcast focused on policy trends and developments in Washington.
Earlier in his career, Chris worked on international policy issues at Time Warner where he was
part of a team that supported then-CEO, Gerald Levin, to develop the Global Business Dialogue on E-Commerce a ground-breaking global organization of CEOs from the U.S., EU, and Asia that developed industry best practices on matters such as online privacy, cross border data flows, and online taxation.
Prior to Time Warner, he served on Capitol Hill as a legislative aide to U.S. Representatives Jan
Meyers (R-KS) and Todd Tiahrt (R-KS).
Chris received his B.A. from the University of Kansas and an M.B.A. from The George
Washington University.
Director of the Program in Human Rights, Catholic University of America
William L. Saunders is Chair Emeritus of the Religious Liberties Practice Group of the Federalist Society. He is also a religious liberty and human rights scholar as well as director of the Center for Human rights at The Catholic University of America. He is Law Fellow with the Institute for Human Ecology, Professor and Director of the Program in Human Rights in the School of Arts & Sciences and Co-director of the Center for Religious Liberty at the Columbus School of Law. Before joining The Catholic University of America, Mr. Saunders served as Senior Vice President and Senior Counsel with Americans United for Life for ten years. From 1999 to 2009, he was Senior Fellow in Bioethics and Human Rights Counsel at the Family Research Council.
Mr. Saunders attended the University of North Carolina at Chapel Hill on a Morehead scholarship. He obtained his degree in law from the Harvard Law School.
Mr. Saunders was featured in Harvard’s first Guide to Conservative Public Interest Law in 2003 and again in the 2008 edition. He served on Harvard’s Advisory Committee for its 2008 celebration of public interest law. A member of the Supreme Court bar, he has authored numerous legal briefs in state, federal, foreign, and international courts.
Mr. Saunders’ book, Unborn Human Life and Fundamental Rights: Leading Constitutional Cases Under Scrutiny, was published in 2019. His articles and book chapters have been published by the university presses of Harvard, Villanova, Brigham Young, Fordham, Georgetown, Houston, Scranton, and the Catholic University of America, as well as by the Intercollegiate Studies Institute, Freedom House, Greenhaven Press, Rowan & Littlefield, Praeger, St. Augustine’s, and Intervarsity press. He has given lectures and participated in debates at many colleges, universities, and law schools, including Princeton, Harvard, Georgetown, and Notre Dame. He delivered the annual J. Michael Miller Lecture at the University of St. Thomas (on international law) in February 2007, the annual R. Wayne Kraft Memorial Lecture (on bioethics) at DeSales University in February 2004 and the annual James Moore Lecture (on human rights violations in Sudan) at Millikin University in 1999. He has also lectured, and/or has been published, in many foreign countries, including Italy, Germany, Poland, Austria, Spain, Greece, Slovakia, Mexico, Qatar, Malaysia, Romania, the Philippines, Hong Kong, and the United Kingdom.
In addition to speaking and writing frequently on bioethics topics, Mr. Saunders has submitted testimony to the President’s Council on Bioethics, as well as to UNESCO’s Committee on Bioethics, and has briefed Congressional staff and state legislatures. He is a regular columnist for the National Catholic Bioethics Quarterly.
Mr. Saunders has appeared often in the media, including BBC World News, CNN, Fox News, Vatican Radio, and National Public Radio. His articles on issues have appeared in a variety of journals, such as First Things, Human Events, Human Life Review, The Legal Times, Communio, The Family in America: A Journal of Public Policy, Ethics & Medics, and Touchstone.
Mr. Saunders served on the official United States delegation to the UN Special Session on Children in 2001/02. In 2011, he was a speaker at an official briefing at the UN, addressing the topic, why euthanasia is not a human right.
In 2004, he served on the NGO Working Committee in connection with the Doha Intergovernmental Conference for the Family.
Mr. Saunders is Senior Fellow with the Religious Freedom Institute, and Affiliated Scholar with the Pellegrino Center for Clinical Ethics at the Georgetown University School of Medicine. He is President of the Fellowship of Catholic Scholars and a member of the boards of the International Association of Catholic Bioethicists, the International Right to Life Federation, the Institute on Religion and Democracy, and the Society of Catholic Social Scientists.
In 1999, Mr. Saunders founded Sudan Relief and Rescue, Inc., to aid the persecuted church in Sudan. He has worked for and written on behalf of the persecuted church for many years.
Charles E. Rice Professor of Law, Concurrent Professor of Political Science, & Director, de Nicola Center for Ethics and Culture, University of Notre Dame Law School
Professor Carter Snead is one of the world’s leading experts on public bioethics – the governance of science, medicine, and biotechnology in the name of ethical goods. His research explores issues relating to neuroethics, enhancement, human embryo research, assisted reproduction, abortion, and end-of-life decision-making.
He is the author of What It Means to be Human: The Case for the Body in Public Bioethics (Harvard University Press, October 2020), which was named by the Wall Street Journal as one of the “Ten Best Books of 2020;” in his review for the same paper, Yuval Levin called it “among the most important works of moral philosophy produced so far in this century.” In May of 2022, it was listed in The New York Times as one of “Ten Books to Understand the Abortion Debate in the United States.” Snead and the book received the 2021 “Expanded Reason Award” (given by Francisco de Vitoria University (Madrid) and the Joseph Ratzinger/Benedict XVI Vatican Foundation), and has been reviewed and discussed in such publications as the Wall Street Journal, The New York Times, New York Post, USA Today, Bloomberg Opinion, Il Foglio, Christian Post, The Review of Metaphysics, American Journal of Jurisprudence, America Magazine, First Things, The New Atlantis, Plough, The Boston Pilot, Public Discourse, Practical Ethics (Oxford University), Legal Ethics Forum, Church Life Journal, Law & Liberty, Angelus News, Mirror of Justice, Crux, Mars Hill Audio Journal, Mercator Net, BioEdge, Front Porch Republic, The National Catholic Register, The American Conservative, Fare Forward, Catholic World Report, The Gospel Coalition, Chronicles: A Magazine of American Culture, The Human Life Review, Eikon, Salvo, The Catholic Thing, The Daily Signal, and National Review.
Additionally, he has written more than 70 journal articles, book chapters, and essays. His scholarly works appear in such publications as the New York University Law Review, the Harvard Law Review Forum, the Vanderbilt Law Review, Constitutional Commentary, Quaderni Costituzionali (Italy’s premier journal of constitutional law), the Yale Journal of Health Policy, Law and Ethics, the Journal of Medicine and Philosophy, and Political Science Quarterly. He is also the editor of two book series for the University of Notre Dame Press – “Catholic Ideas for a Secular World” and “Notre Dame Studies in Bioethics and Medical Ethics.” Snead teaches Law & Bioethics, Health Law, Torts, and Constitutional Criminal Procedure.
In addition to his scholarship and teaching, Snead has provided advice on the legal and public policy dimensions of bioethical questions to officials in all three branches of the U.S. government, and in several intergovernmental fora. Prior to joining the law faculty at Notre Dame, Snead served as general counsel to The President’s Council on Bioethics (Chaired by Dr. Leon R. Kass), where he was the primary drafter of the 2004 report, “Reproduction and Responsibility: The Regulation of New Biotechnologies.” He has testified in the U.S. House of Representatives on regulatory questions concerning RU-486 (the abortion pill). In 2013, he testified in the Texas state legislature on the constitutionality of a proposed fetal pain bill. Snead led the U.S. government delegation to UNESCO and served as its chief negotiator for the Universal Declaration on Bioethics and Human Rights, adopted in October 2005. He served as the U.S. government’s Permanent Observer to the Council of Europe’s Steering Committee on Bioethics, where he assisted in its efforts to elaborate international instruments and standards for the ethical governance of science and medicine. In conjunction with the American Association for the Advancement of Science, he has lectured to state and federal judges on the uses of neuroimaging in the courtroom. He regularly serves as an expert witness on bioethical matters before federal courts.
In 2008, he was appointed by the director-general of UNESCO to a four-year term on the International Bioethics Committee, a 36-member body of independent experts that advises member states on bioethics, law, and public policy. The IBC is the only bioethics commission in the world with a global mandate. In 2016, he was appointed to the Pontifical Academy for Life, the principal bioethics advisory body to Pope Francis. He is also an elected fellow of The Hastings Center, the oldest independent bioethics research institute in the world.
Snead received his J.D., magna cum laude, from Georgetown University, where he was elected to the Order of the Coif, and his bachelor of arts from St. John’s College in Annapolis, Maryland. He clerked for Judge Paul J. Kelly Jr. of the U.S. Court of Appeals for the Tenth Circuit.
Chief Counsel, U.S. Food and Drug Administration; Deputy General Counsel, Department of Health and Human Services
Stacy Cline Amin serves as Chief Counsel of the Food and Drug Administration and Deputy General Counsel of the Department of Health and Human Services. Stacy serves as the senior legal advisor to the Commissioner, FDA leadership, the HHS General Counsel and Departmental leadership on FDA regulatory and litigation matters. Stacy leads an office of 165 lawyers and support staff that provide counseling and litigation support to the agency.
Stacy previously served as Special Assistant to the President and Senior Associate Counsel to the President, serving as the senior legal advisor on matters relating to the Department of Health and Human Services. In that role, Stacy advised on critical matters arising under the Food Drug and Cosmetic Act, helped lead the Administration's efforts to combat the opioid crisis, led multi-agency teams in the evaluation of high profile administrative actions, and successfully coordinated litigation strategy with the Department of Justice.
Prior to joining the White House, Stacy served as the Chief Counsel of the Senate Health, Education, Labor and Pensions Committee and as a Counsel for the House Energy & Commerce Committee. In Congress, Stacy frequently advised on Food Drug and Cosmetic Act issues and led bipartisan and bicameral investigations to promote patient safety and global public health. These efforts supported a number of legislative accomplishments, including passage of the Drug Quality and Security Act of 2013 and the 21st Century Cures Act of 2016.
Earlier in her career, she served as an Associate at Sullivan & Cromwell LLP and as a law clerk to the Hon. John R. Gibson on the U.S. Court of Appeals for the Eighth Circuit. She graduated cum laude from Harvard Law School and summa cum laude from The George Washington University.
Attorney General, Alaska
Stephen J. Cox serves as the 28th Attorney General of the State of Alaska, where he oversees the state’s legal affairs and serves as the chief prosecutor with oversight of all district attorneys, general counsel to the Governor and executive branch, and represents the State in all civil and criminal cases in federal and state court. He brings to the role a proven record of public service at the highest levels of the U.S. Department of Justice, combined with deep experience in Alaska’s private sector and community life.
Before his appointment, he was Senior Vice President, Chief Legal and Strategy Officer of Bristol Bay Industrial—an investment platform of the Bristol Bay Native Corporation—acting as the chief legal officer for the industrial services portfolio on behalf of the Alaska Native shareholders in the Bristol Bay region. In that role, he led legal, compliance, and strategic planning for major energy, infrastructure, and utility projects across the State and in the Lower 48.
Earlier in his career, beginning in 2011, Cox served as in-house counsel for Apache Corporation, where he was the principal attorney for Apache Alaska and focused on new ventures and exploratory work in Cook Inlet, including seismic initiatives and ongoing regulatory coordination with state agencies.
Cox is deeply rooted in Anchorage’s community and faith life. He and his family attend Holy Family Old Cathedral in downtown Anchorage and support Mission Alaska, the Dominican friars’ outreach ministry under the Western Dominican Province. He was the founding board president and chairman of a new classical school in South Anchorage.
On the national stage, Cox held senior leadership roles in the U.S. Department of Justice under the Trump Administration. As Deputy Associate Attorney General, he co-chaired the DOJ’s Regulatory Reform Task Force and the Working Group on Corporate Enforcement and Accountability, and helped implement landmark policies aimed at curbing regulatory overreach and aligning enforcement with fairness and oversight. Later, as U.S. Attorney for the Eastern District of Texas, he oversaw prosecutions and civil litigation spanning 43 counties, prioritizing healthcare fraud, elder fraud, and violent crime while ensuring enforcement remained transparent and fair.
Earlier in his career, Cox practiced complex litigation at a major international law firm, served as counselor to the Director of U.S. Immigration and Customs Enforcement, and helped lead the William H. Webster Commission, which reviewed FBI counterterrorism intelligence and operations following the Fort Hood tragedy.
He began his legal career with a clerkship for Judge J. L. Edmondson of the U.S. Court of Appeals for the Eleventh Circuit. Cox earned a B.S. in Computer Science from Texas A&M University and a J.D., summa cum laude, from the University of Houston Law Center. He and his wife, Cristina, are raising their three children in Anchorage, and have made Alaska their home.
Operating Advisor, Clayton, Dubilier & Rice
Anand Shah, MD, is an Operating Advisor at private equity firm Clayton, Dubilier & Rice. Dr. Shah develops and identifies potential investment opportunities in the healthcare industry with a focus on health care services, including the provider, payer, and HCIT sectors. He also serves as an advisor to the firm’s portfolio companies.
A nationally recognized physician leader and health policy expert, Dr. Shah has extensive healthcare experience in the senior-most levels of the U.S. government, private sector, and as a physician. He was previously the Deputy Commissioner for Medical and Scientific Affairs at the U.S. Food and Drug Administration (FDA). Dr. Shah led consensus policy development for fit-for-purpose programs including Advanced Manufacturing, the Coronavirus Treatment Acceleration Program, Covid vaccine development, digital health, consumer protection, and decentralized clinical trials. During the Covid pandemic, he led FDA’s policy development for preparedness and recovery efforts. Dr. Shah represented FDA with top-level policy makers of the White House and Cabinet, Governors and local governments, and regularly led briefings with Congressional leadership.
He previously served in two senior leadership roles at the Centers for Medicare & Medicaid Services (CMS). As Senior Medical Advisor, he was the primary counselor for agency-wide policy related to medical and scientific innovation. Dr. Shah established consensus on several critical policy initiatives including aligning payment and prevention to increase Medicare beneficiaries’ access to novel antimicrobials, expanding patients’ access to cell and gene therapies, and streamlining Medicare access to breakthrough technologies. As the Chief Medical Officer of the Center for Medicare & Medicaid Innovation (CMMI), Dr. Shah led the clinical design of novel value-based payment and service delivery models including those for primary and specialty care.
Dr. Shah specializes in the early detection, surveillance, and treatment of prostate cancer, and previously developed and led a survivorship clinic for patients on cancer clinical trials at the National Institutes of Health. His scientific track record includes publications in the New England Journal of Medicine, JAMA, Health Affairs, Cancer, and Nature Reviews Drug Discovery. Dr. Shah is an Adjunct Professor with the Department of Medical Ethics and Health Policy and an Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania.
Dr. Shah was chief resident during his radiation oncology residency at Columbia University. He concurrently earned his MD from the University of Pennsylvania and an MPH in health care management and policy from the Harvard School of Public Health. Dr. Shah graduated with honors from Duke University with a degree in economics. He also served as a Canada-U.S. Fulbright Scholar.
Senior Fellow, National Center for Policy Analysis
Senior Fellow at the National Center for Policy Analysis (NCPA) and author of Free To Choose Medicine: Better Drugs Sooner at Lower Cost
Adjunct Fellow, Competitive Enterprise Institute
Gregory Conko is an Adjunct Fellow at the Competitive Enterprise Institute and Vice President of Programs at DonorsTrust. His research at CEI focuses on health care, food and drug regulation, agriculture and agricultural trade, and nutrition and public health. He also has broad expertise in science and environmental policy and in administrative and regulatory law.
Since 2021, Conko has managed the grants and grantee programs at the donor-advised fund sponsor DonorsTrust, but he continues to research and write on policy matters for the Competitive Enterprise Institute. Before joining DonorsTrust, Conko was Deputy Director of the George Mason University Law & Economics Center, a Senior Fellow and later Executive Director of CEI.
Conko is the author or co-author of numerous books, studies, and articles, and Barron’s called his book, The Frankenfood Myth: How Protest and Politics Threaten the Biotech Revolution, co-authored with Henry I. Miller, one of the 25 best books of 2004. His other writings have appeared in such journals as Nature Biotechnology, Transgenic Research, Health Matrix: Journal of Law & Medicine, and the Cumberland Law Review, and in such newspapers as the Financial Times, The Wall Street Journal, Los Angeles Times, and USA Today.
Conko is a member of the Federalist Society’s Regulatory Transparency Project Working Group on FDA & Health, a member of the American Council on Science and Health’s Board of Scientific and Policy Advisors. He received a JD degree magna cum laude from the George Mason University School of Law and a BA in political science and history from American University. He lives in Virginia with his wife and son.
NIST’s Proposed Framework for a New Approach to Bayh-Dole March-in: What You Need to Know
Susan G. Braden, Jorge L. Contreras, Charles Crain, Jeffrey E. Depp, Chris Israel
The National Institute of Standards and Technology (NIST) seeks comments on the Draft Interagency Guidance...
Talks with Authors: What It Means to Be Human
William L. Saunders, O. Carter Snead
In What It Means to Be Human - The Case for the Body in Public...
Capital Conversations: COVID-19 and FDA; Medical, Legal, and Regulatory Perspectives
Stacy Cline Amin, Stephen Cox, Anand Shah
During the COVID-19 pandemic, the United States Food and Drug Administration (FDA) has sought to...
Free To Choose Medicine
Bartley J. Madden, Gregory Conko
Note from the Editor: This article is about the Free To Choose Medicine concept....
Tobacco-Free FDA
For 58 of the past 60 years, since Congress passed the 1938 Food, Drug and...